Insiders Updates MaxCyte Inc’s latest rating changes from various analysts MaxCyte Inc’s recently made public that its Director Hemrajani Rekha acquired Company’s shares for reported $22378.0 on Jun 25 ’25.
Insiders Updates MXCT stock price expected to increase by 6 in 12 months Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. MaxCyte Inc